Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
About the Project We are seeking a talented and dedicated team of scientists, bioinformaticians and support colleaguesto join the ground-breaking PharosAI initiative – a £43.6M national programme co
-
Health Records Research (EHR) Group for an experienced epidemiologist/statistician to join an NIHR-funded programme of research (The INTEGRATE programme) in collaboration with the National Institute
-
the MRes programmes, as required. In addition, the postholder will contribute to the 1st year tutorial programme, an undergraduate fieldtrip and undergraduate dissertation supervision, as required
-
science projects aligned with the university’s strategic and operational goals Take ownership of data analysis workflows including data extraction, preparation, modelling, and reporting Promote data
-
pay benefit, free on-site gym and wellbeing centre a comprehensive learning and development programme and support for your CPD Prospective applicants are encouraged in the first instance to contact
-
collaborations with external industry meet our ambitious goals for EDI across the sector. They will contribute to a range of Access Programme activities at the National Lab and Challenge Projects in the CDT
-
work. The candidate is expected to support current PhD students in the group, write and publish research papers. About You Candidates should have a PhD in mechanical engineering, orthopedic engineering
-
About the Project We are seeking a talented and dedicated team of scientists, bioinformaticians and support colleaguesto join the ground-breaking PharosAI initiative – a £43.6M national programme co
-
Faculty of Science & Engineering Operations Administrator (Permanent & Maternity Cover) We are delighted to be recruiting two Operations Administrators to join the Faculty of Science & Engineering
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing